Verastem Inc VSTM shares are trading higher by $1.14 (30 percent) at $4.99 in Wednesday's session.
The catalyst for the rally is the announcement of positive top-line data from the Pivot Phase 3 DUO study for the treatment of certain types of Leukemia and Lymphoma.
Its much higher opening print is only 2 cents from the session high of $5.55. That marks the first time the stock has traded over $5.00 since September 25, 2015, when it peaked at $6.00. Profit-takers have come into the stock and nudged it lower with $4.83 standing as the low for the day as of 1:10 p.m. EST.
It's also attempting to post its first close over $5.00 since September 25, 2015, when it ended that session at $5.67.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.